Neurochemical and electrophysiological characteristics of rat striatal neurons in primary culture.

PubWeight™: 0.89‹?›

🔗 View Article (PMC 2923039)

Published in J Comp Neurol on January 10, 2006

Authors

Torsten Falk1, Shiling Zhang, Emilie L Erbe, Scott J Sherman

Author Affiliations

1: Department of Neurology, The University of Arizona, Tucson, 85724-5023, USA.

Articles citing this

MEF-2 regulates activity-dependent spine loss in striatopallidal medium spiny neurons. Mol Cell Neurosci (2010) 1.30

Serotonin2C receptor localization in GABA neurons of the rat medial prefrontal cortex: implications for understanding the neurobiology of addiction. Neuroscience (2007) 1.16

Distinct roles of presynaptic dopamine receptors in the differential modulation of the intrinsic synapses of medium-spiny neurons in the nucleus accumbens. BMC Neurosci (2007) 0.93

Dopamine-dependent tuning of striatal inhibitory synaptogenesis. J Neurosci (2010) 0.92

Endogenous opiates and behavior: 2006. Peptides (2007) 0.92

Control of striatal signaling by g protein regulators. Front Neuroanat (2011) 0.87

All-trans-retinoid acid induces the differentiation of encapsulated mouse embryonic stem cells into GABAergic neurons. Differentiation (2012) 0.83

Reduced striatal dopamine D1-D2 receptor heteromer expression and behavioural subsensitivity in juvenile rats. Neuroscience (2012) 0.83

A computer-based quantitative systems pharmacology model of negative symptoms in schizophrenia: exploring glycine modulation of excitation-inhibition balance. Front Pharmacol (2014) 0.82

A Humanized Clinically Calibrated Quantitative Systems Pharmacology Model for Hypokinetic Motor Symptoms in Parkinson's Disease. Front Pharmacol (2016) 0.78

Minimal Change in the cytoplasmic calcium dynamics in striatal GABAergic neurons of a DYT1 dystonia knock-in mouse model. PLoS One (2013) 0.78

Effect of the environmental pollutant hexachlorobenzene (HCB) on the neuronal differentiation of mouse embryonic stem cells. Int J Environ Res Public Health (2013) 0.77

GABAA receptor activity shapes the formation of inhibitory synapses between developing medium spiny neurons. Front Cell Neurosci (2015) 0.75

Articles cited by this

Primary structure and functional expression of a mouse inward rectifier potassium channel. Nature (1993) 8.20

Inactivation properties of voltage-gated K+ channels altered by presence of beta-subunit. Nature (1994) 4.38

Functional anatomy of thalamus and basal ganglia. Childs Nerv Syst (2002) 2.42

Dopamine D1 and D2 receptor Co-activation generates a novel phospholipase C-mediated calcium signal. J Biol Chem (2004) 2.32

Are neostriatal dopamine receptors co-localized? Trends Neurosci (1993) 2.28

Tuning pacemaker frequency of individual dopaminergic neurons by Kv4.3L and KChip3.1 transcription. EMBO J (2001) 2.08

Electron microscopic analysis of D1 and D2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships with motor corticostriatal afferents. J Neurosci (1995) 1.91

'New' functions for 'old' proteins: the role of the calcium-binding proteins calbindin D-28k, calretinin and parvalbumin, in cerebellar physiology. Studies with knockout mice. Cerebellum (2002) 1.87

Potassium currents responsible for inward and outward rectification in rat neostriatal spiny projection neurons. J Neurosci (1995) 1.67

Subthalamic GAD gene therapy in a Parkinson's disease rat model. Science (2002) 1.40

D1 and D2 dopamine receptor function in the striatum: coactivation of D1- and D2-dopamine receptors on separate populations of neurons results in potentiated immediate early gene response in D1-containing neurons. J Neurosci (1995) 1.37

Organization of the basal ganglia: the importance of axonal collateralization. Trends Neurosci (2000) 1.31

Anatomy of the dopamine system in the basal ganglia. Trends Neurosci (2000) 1.30

Flavonoids protect neurons from oxidized low-density-lipoprotein-induced apoptosis involving c-Jun N-terminal kinase (JNK), c-Jun and caspase-3. Biochem J (2001) 1.30

Activation of heteromeric G protein-gated inward rectifier K+ channels overexpressed by adenovirus gene transfer inhibits the excitability of hippocampal neurons. Proc Natl Acad Sci U S A (1997) 1.24

Effects of levodopa on endocannabinoid levels in rat basal ganglia: implications for the treatment of levodopa-induced dyskinesias. Eur J Neurosci (2003) 1.16

Genes and channels: patch/voltage-clamp analysis and single-cell RT-PCR. Cell Tissue Res (2000) 1.11

ROMK1 (Kir1.1) causes apoptosis and chronic silencing of hippocampal neurons. J Neurophysiol (2000) 1.04

Neuroanatomical relationship between type 1 cannabinoid receptors and dopaminergic systems in the rat basal ganglia. Neuroscience (2003) 1.03

CB1 cannabinoid receptor signalling in Parkinson's disease. Curr Opin Pharmacol (2003) 1.03

Activation of dopamine D1-like receptors excites LTS interneurons of the striatum. Eur J Neurosci (2002) 1.02

Comparison of the distributions of D1 and D2 dopamine receptor mRNAs in rat brain. Neuropsychopharmacology (1991) 1.02

D1 dopamine receptor-induced cyclic AMP-dependent protein kinase phosphorylation and potentiation of striatal glutamate receptors. J Neurochem (1999) 1.01

Increased striatal pre-proenkephalin B expression is associated with dyskinesia in Parkinson's disease. Exp Neurol (2003) 0.99

Substance P receptor expression by inhibitory interneurons of the rat hippocampus: enhanced detection using improved immunocytochemical methods for the preservation and colocalization of GABA and other neuronal markers. J Comp Neurol (2001) 0.99

Upregulation of preprodynorphin and preproenkephalin mRNA expression by selective activation of group I metabotropic glutamate receptors in characterized primary cultures of rat striatal neurons. Brain Res Mol Brain Res (2001) 0.97

Inwardly rectifying potassium (IRK) currents are correlated with IRK subunit expression in rat nucleus accumbens medium spiny neurons. J Neurosci (1998) 0.96

Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation. Hum Gene Ther (2001) 0.94

Neurochemical organization of the human basal ganglia: anatomofunctional territories defined by the distributions of calcium-binding proteins and SMI-32. J Comp Neurol (2002) 0.91

Ethanol sensitivity and subunit composition of NMDA receptors in cultured striatal neurons. Neuropharmacology (1998) 0.91

Intracellular organization of hippocampal neurons during the development of neuronal polarity. J Cell Sci Suppl (1991) 0.91

Molecular genetic approaches to the targeted suppression of neuronal activity. Curr Biol (2001) 0.91

Two types of A-current differing in voltage-dependence are expressed by neurons of the rat neostriatum. Neurosci Lett (1989) 0.90

The neostriatal mosaic: multiple levels of compartmental organization. J Neural Transm Suppl (1992) 0.90

Preprodynorphin-, preproenkephalin-, and preprotachykinin-expressing neurons in the rat neostriatum: an analysis by immunocytochemistry and retrograde tracing. J Comp Neurol (1997) 0.90

Cloning, functional expression and mRNA distribution of an inwardly rectifying potassium channel protein. FEBS Lett (1995) 0.89

Increase of preproenkephalin mRNA levels in the putamen of Parkinson disease patients with levodopa-induced dyskinesias. J Neuropathol Exp Neurol (2002) 0.88

6-Hydroxydopamine lesions of rat substantia nigra up-regulate dopamine-induced phosphorylation of the cAMP-response element-binding protein in striatal neurons. Proc Natl Acad Sci U S A (1994) 0.88

Kir2 potassium channels in rat striatum are strategically localized to control basal ganglia function. Brain Res Mol Brain Res (2003) 0.87

Calretinin is largely localized to a unique population of striatal interneurons in rats. Brain Res (1996) 0.87

Neurophysiological changes of spiny neurons in rat neostriatum after transient forebrain ischemia: an in vivo intracellular recording and staining study. Neuroscience (1995) 0.86

Calcium-binding proteins in primate basal ganglia. Neurosci Res (1996) 0.86

Microtubule-associated proteins, phosphorylation gradients, and the establishment of neuronal polarity. Perspect Dev Neurobiol (1996) 0.85

Potentiation of dopamine-induced cAMP formation by group I metabotropic glutamate receptors via protein kinase C in cultured striatal neurons. Eur J Neurosci (1998) 0.84

Calcium-binding proteins in the human developing brain. Adv Anat Embryol Cell Biol (2002) 0.84

Differential regulation of cholinergic and peptidergic development in the rat striatum in culture. Dev Biol (1986) 0.84

Coexistence of inhibitory dopamine D-1 and excitatory D-2 receptors on the same caudate nucleus neurons. Life Sci (1987) 0.84

Immunohistochemical study on the distribution of six members of the Kv1 channel subunits in the rat basal ganglia. Brain Res (2000) 0.84

Characterization of opioid receptors in cultured neurons. J Neurochem (1990) 0.83

Somatostatin modulates Ca2+ currents in neostriatal neurons. Neuroscience (2002) 0.83

Developmental regulation of the A-type potassium-channel current in hippocampal neurons: role of the Kvbeta 1.1 subunit. Neuroscience (2003) 0.82

Nicotine inhibits slowly inactivating K+ currents in rat cultured striatal neurons. Pflugers Arch (1997) 0.80

Synergistic effects of acetylcholine and glutamate on the release of arachidonic acid from cultured striatal neurons. J Neurochem (1995) 0.80

Emergence of a synaptic neuronal network within primary striatal cultures seeded in serum-free medium. Neuroscience (1995) 0.79

Are GAD65 and GAD67 associated with specific pools of GABA in brain? Perspect Dev Neurobiol (1998) 0.79

Developmental expression of proenkephalin mRNA in rat striatum and in striatal cultures. Brain Res (1988) 0.78

Localization of D1 dopamine receptors on live cultured striatal neurons by quantitative fluorescence microscopy. Brain Res (1996) 0.77

Activation of dopamine D(3) receptors induces c-fos expression in primary cultures of rat striatal neurons. J Neurosci Res (2000) 0.77

Selective susceptibility of cultured striatal neurons to kainic acid. J Neurosci Res (1992) 0.76

Effects of semiconductor substrate and glia-free culture on the development of voltage-dependent currents in rat striatal neurones. Eur Biophys J (2001) 0.76

Viral vector-mediated expression of K+ channels regulates electrical excitability in skeletal muscle. Gene Ther (2001) 0.76

Articles by these authors

Hold your horses: impulsivity, deep brain stimulation, and medication in parkinsonism. Science (2007) 4.57

Subthalamic nucleus stimulation reverses mediofrontal influence over decision threshold. Nat Neurosci (2011) 2.26

The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study. BMC Med (2008) 2.10

Frailty in Parkinson's disease and its clinical implications. Parkinsonism Relat Disord (2007) 1.47

A role for dopamine in temporal decision making and reward maximization in parkinsonism. J Neurosci (2008) 1.42

Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: the GenePD study. Mov Disord (2008) 1.41

Understanding decision-making deficits in neurological conditions: insights from models of natural action selection. Philos Trans R Soc Lond B Biol Sci (2007) 1.35

A dopaminergic basis for working memory, learning and attentional shifting in Parkinsonism. Neuropsychologia (2008) 1.29

Retinal pigment epithelial cell transplantation could provide trophic support in Parkinson's disease: results from an in vitro model system. Exp Neurol (2006) 1.07

Does integrative medicine enhance balance in aging adults? Proof of concept for the benefit of electroacupuncture therapy in Parkinson's disease. Gerontology (2014) 1.01

Subthalamic nucleus deep brain stimulation improves deglutition in Parkinson's disease. Mov Disord (2008) 0.98

Pigment epithelium derived factor (PEDF) is neuroprotective in two in vitro models of Parkinson's disease. Neurosci Lett (2009) 0.94

Replication of association between ELAVL4 and Parkinson disease: the GenePD study. Hum Genet (2008) 0.91

Vascular endothelial growth factor-B is neuroprotective in an in vivo rat model of Parkinson's disease. Neurosci Lett (2011) 0.89

Vascular endothelial growth factor B (VEGF-B) is up-regulated and exogenous VEGF-B is neuroprotective in a culture model of Parkinson's disease. Mol Neurodegener (2009) 0.88

PEDF and VEGF-A output from human retinal pigment epithelial cells grown on novel microcarriers. J Biomed Biotechnol (2012) 0.87

The subthalamic nucleus contributes to post-error slowing. J Cogn Neurosci (2014) 0.87

The yin and yang of VEGF and PEDF: multifaceted neurotrophic factors and their potential in the treatment of Parkinson's Disease. Int J Mol Sci (2010) 0.82

Effects of the novel glycopeptide opioid agonist MMP-2200 in preclinical models of Parkinson's disease. Brain Res (2011) 0.80

Extramammary Paget's diseases in men from the Shanghai area: its association with PSA level increase. APMIS (2010) 0.77

Neuroprotective effects of NKN on focal cerebral ischemia in rats. Turk Neurosurg (2012) 0.77

CNS penetration of the opioid glycopeptide MMP-2200: a microdialysis study. Neurosci Lett (2012) 0.76

A herpes simplex viral vector expressing green fluorescent protein can be used to visualize morphological changes in high-density neuronal culture. Electron J Biotechnol (2001) 0.75